Lance Armstrong Foundation establishes Endowed Chair in Oncology at Indiana University
AUSTIN, Texas -- When 25-year-old Lance Armstrong, already a world-class cyclist, was diagnosed with an aggressive form of testicular cancer in 1996, he sought the pioneering treatment developed by Lawrence H. Einhorn, M.D., a leading clinical oncologist at the Indiana University Cancer Center and an Indiana University Distinguished Professor.
The Lance Armstrong Foundation is honoring Dr. Einhorn and inspiring future innovations in cancer treatment through the establishment of the Lance Armstrong Foundation Chair in Oncology at Indiana University. Funded through a $1.5 million endowment, the chair will support the research and scholarly needs of the named professor and provide seed money for program development and growth.
"This endowed chair provides permanent and visible recognition of Dr. Einhorn's extraordinary contribution to cancer patients and the medical discipline of oncology," said Mitch Stoller, LAF president and chief executive officer. "We are pleased to award $1.5 million to Indiana University to aid in the efforts of researchers and clinicians to improve the quality of life of cancer patients."
"Words cannot express the deep gratitude, joy and excitement I felt upon learning of the Foundation's gift," said Dr. Einhorn, who treats about 100 patients annually and conducts research on improving patient therapies. "Cancer is a scary diagnosis for anyone, but Lance, through his personal advocacy and the work of the Lance Armstrong Foundation, has given hope to millions of survivors. This extraordinary gift will enable us to transform that hope into real results for people battling cancer."
Dr. Einhorn is most widely known for his 1974 work on a revolutionary new chemotherapy regimen that increased the testicular cancer cure rate from 10 percent to 95 percent. Testicular cancer affects one in 500 men. In addition to his work with testicular cancer, Dr. Einhorn is an internationally recognized authority on other types of urologic cancer, lung cancer and certain other tumors.
He has published hundreds of professional articles and has received numerous prestigious awards including the American Association for Cancer Research Richard and Hinda Rosenthal Award and the American Society of Clinical Oncology Karnofsky Award. He also has received the General Motors Kettering Award for Cancer Research and the American Cancer Society Medal of Honor.
Source: Eurekalert & othersLast reviewed: By John M. Grohol, Psy.D. on 21 Feb 2009
Published on PsychCentral.com. All rights reserved.